RecruitingNCT03032835

Partners Calciphylaxis Biobank

Partners Calciphylaxis Biobank and Patient Registry


Sponsor

Massachusetts General Hospital

Enrollment

300 participants

Start Date

Jan 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Calciphylaxis, a vascular calcification disorder, is a rare and serious disorder characterized by calcification of dermal arterioles. There are significant gaps in the understanding of the pathophysiology and risk factors for calciphylaxis. At present, there is no effective treatment. Uncertain pathobiology, rare incidence and lack of collaborative approach have been some of the major limiting factors towards treating calciphylaxis. The Partners Calciphylaxis Biorepository (PCB) aims to address these gaps within calciphylaxis research by utilizing existing and, when necessary, developing new infrastructure to support the consent of patients and the collection of dedicated samples for a calciphylaxis repository.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Male or female ≥18 years old
  • Skin lesions consistent with calciphylaxis diagnosis as determined by the treating clinician
  • Informed of the investigational nature of the study and sign written Informed consent OR are eligible for surrogate consent process based on impaired decision making

Exclusion Criteria2

  • Patients \<18 years of age
  • Prisoners

Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03032835


Related Trials